Compare Neurocrine Biosciences Inc (NBIX) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Simon Property Group Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Simon Property Group Inc trades at $227 (market cap $74.00B). The key difference: Simon Property Group Inc is far larger — about 4.3× Neurocrine Biosciences Inc's market cap, and Simon Property Group Inc pays a 3.86% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | SPG | |
|---|---|---|
Market Cap | $17.40B | $74.00B |
Sector | Health | Real Estate |
52-Week High | $180.55 | $228.70 |
52-Week Low | $123.10 | $160.68 |
Enterprise Value | $16.49B | $102.48B |
Dividend Yield | — | 3.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
